Let’s see if it works out. This guy Paul Sax is very well respected.
Could This Be Our First Effective, Inexpensive, Widely Available Outpatient Treatment for COVID-19?
It’s fluvoxamine. This rarely used antidepressant, long off-patent, has quietly been going through high-quality clinical studies for treatment of COVID-19. It certainly won’t be endorsed or promoted by any deep-pocketed pharmaceutical company, but deserves some attention nonetheless. Here’s why...
blogs.jwatch.org